Cite
HARVARD Citation
Zhou, J. et al. (2017). A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects: reply. Journal of thrombosis and haemostasis. pp. 2081-2083. [Online].